Skip to ContentSkip to Navigation
About us Latest news News News articles

Rector Magnificus Cisca Wijmenga receives 2022 Galjaard Award

20 April 2022

On 21 April, Prof. Cisca Wijmenga will receive the 2022 Galjaard Award from the Dutch Society for Human Genetics (NVHG). Once every two years, the NVHG board selects the winner of the Galjaard Award, who is then presented with the award during an award ceremony at the annual NVHG conference. As part of the ceremony, the award-winner holds a lecture providing their perspective on the field of medical genetics.

The Galjaard Award is a prestigious life-time achievement award to honour scientists who have successfully brought the topic of genetics to the attention of the general public and/or who have played a pivotal role in the field of medical genetics in the Netherlands. The award is named after Prof. Hans Galjaard (born in 1935), one of the most decorated geneticists of the Netherlands, who is well-known for his interviews on radio and television as well as for his world-renowned pioneering work in the field of medical genetics, and prenatal diagnostics in particular.

Prof. Cisca Wijmenga
Prof. Cisca Wijmenga
Last modified:25 April 2022 3.32 p.m.
View this page in: Nederlands

More news

  • 27 August 2024

    UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling

    Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...

  • 17 July 2024

    Veni-grants for ten researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.

  • 16 July 2024

    Medicine still subjects to male bias

    Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.